Linezolid is a synthetic antibiotic that functions through the inhibition of bacterial protein synthesis by binding to ribosomal ribonucleic acid (rRNA). Deliverable in both intravenous and oral form, with a low level of resistance amongst Methicillin-resistant Staphylococcus aureus (MRSA) strains, it is recommended for a wide range of gram-positive infections. We present a case of a male patient who underwent endovascular abdominal aortic aneurysm repair complicated by abdominal sepsis due to bowel ischemia; several days after linezolid therapy was initiated, he presented with signs of lactic acidosis. After excluding other sources such as metabolic, hypoxia, or organ damage, the resulting lactic acidosis was determined to be a side effect of linezolid.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746010PMC
http://dx.doi.org/10.7759/cureus.11514DOI Listing

Publication Analysis

Top Keywords

lactic acidosis
12
linezolid
4
linezolid induced
4
induced lactic
4
acidosis side
4
side clinician
4
clinician aware
4
aware linezolid
4
linezolid synthetic
4
synthetic antibiotic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!